Biomarkers of Sepsis-Associated Acute Kidney Injury: From Conventional Indicators to Emerging Precision Medicine
Keywords:
Sepsis-associated acute kidney injury; Biomarkers; Precision medicineAbstract
Background: Sepsis-associated acute kidney injury (SA-AKI) is one of the most frequent and devastating complicationsof sepsis, contributing substantially to intensive care unit admissions, prolonged hospitalization, chronic kidney disease,and mortality. Early diagnosis remains challenging because conventional indicators, including serum creatinine and urineoutput, often reflect renal dysfunction only after significant kidney injury has already occurred. This diagnostic delaylimits opportunities for timely intervention and highlights the need for more sensitive and specific biomarkers capable of identifying kidney injury at an earlier stage
Downloads
References
Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis
. JAMA. 2016;315(8):801-810. doi:10.1001/jama.2016.0287.
Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic
Shock 2021. Crit Care Med. 2021;49(11):e1063-e1143. doi:10.1097/CCM.0000000000005337.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.


